Arbitrating Antitrust Follow-on Damages Claims: A European Perspective (Part 1)
This post, which will be presented in two parts, proposes to pick-up on a subject addressed in an earlier commentary posted by R. Bellinghausen and J. Grothaus regarding the CJEU’s decision in CDC v. Akzo Nobel et al [See Judgment C-352/13]. As highlighted in the earlier post, the CJEU’s recent decision raises a number of questions…